Source comparison
Tesamorelin Ipamorelin Stack Protocol: Dosing Schedule Comparison
The table below outlines three common dosing schedules used in the tesamorelin ipamorelin stack protocol across research settings, comparing daily administration frequency, timing strategy, and observed outcomes. Standard Dual-Dose 1mg once daily (morning) 200
This comparison does not assign a generated winner or score.
- The table below outlines three common dosing schedules used in the tesamorelin ipamorelin stack protocol across research settings, comparing daily administration frequency, timing strategy, and observed outcomes.
- Standard Dual-Dose
- 1mg once daily (morning)
- 200mcg twice daily (morning, pre-bed)
- Moderate sustained elevation with nocturnal amplification
- Metabolic studies targeting visceral fat and lean mass
- Balances convenience with efficacy. Suitable for extended observation periods without excessive injection burden
- High-Frequency Triple-Dose
- 2mg once daily (evening)
- 300mcg three times daily (morning, post-exercise, pre-bed)
- High sustained GH with pronounced post-exercise and nocturnal peaks
- Performance and recovery research, body composition remodeling
- Maximum GH output but requires strict adherence. Best for short-term intensive protocols (8–12 weeks)
- Conservative Single-Dose
- 200mcg once daily (pre-bed)
- Moderate with targeted nocturnal pulse
- Initial tolerance assessment, lipodystrophy models, older populations
- Minimizes injection frequency and side effect risk. Useful for dose-finding studies or populations sensitive to GH elevation
- The standard dual-dose protocol represents the most common framework in 2026 research applications. It provides sustained GH elevation without the injection burden of triple-dosing, while the pre-bed ipamorelin dose capitalizes on natural nocturnal GH pulsatility. High-frequency protocols suit short-term, intensive studies where maximizing GH output is the priority, but adherence drops sharply beyond 8 weeks. Conservative single-dose schedules work well for initial tolerance studies or when investigating minimum effective dosing thresholds.